Human Genome Epidemiology Literature Finder
|
Records 1 - 21 (of 21 Records) |
| Query Trace: Disease and GGH[original query] |
|---|
| The pharmacogenetics of methotrexate in inflammatory bowel disease. Pharmacogenetics and genomics 2005 Oct 15 (10): 705-11. Herrlinger Klaus R, Cummings J R Fraser, Barnardo Martin C N M, Schwab Matthias, Ahmad Tariq, Jewell Derek |
| Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients. Pharmacogenomics 2007 Feb 8 (2): 141-50. van der Straaten R J H M, Wessels Judith A M, de Vries-Bouwstra Jeska K, Goekoop-Ruiterman Yvonne P M, Allaart Cornelia F, Bogaartz Judith, Tiller Marco, Huizinga Tom W J, Guchelaar Henk-J |
| Interaction of genes from influx-metabolism-efflux pathway and their influence on methotrexate efficacy in rheumatoid arthritis patients among Indians. Pharmacogenetics and genomics 2008 Dec 18 (12): 1041-9. Sharma Shruti, Das Mitashree, Kumar Ashok, Marwaha Vishal, Shankar Subramanian, Aneja Ritu, Grover Rahul, Arya Vivek, Dhir Varun, Gupta Rajiva, Kumar Uma, Juyal Ramesh C, B K Thel |
| XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer. Gynecologic oncology 2008 Dec 111 (3): 509-15. Kim Kidong, Kang Soon-Beom, Chung Hyun Hoon, Kim Jae Weon, Park Noh-Hyun, Song Yong-Sa |
| Associations between single nucleotide polymorphisms in folate uptake and metabolizing genes with blood folate, homocysteine, and DNA uracil concentrations. The American journal of clinical nutrition 2008 Oct 88 (4): 1149-58. DeVos Lauren, Chanson Aurelie, Liu Zhenhua, Ciappio Eric D, Parnell Laurence D, Mason Joel B, Tucker Katherine L, Crott Jimmy |
| Correlation between polymorphisms of the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer: a North Central Cancer Treatment Group-based exploratory study. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Sep 5 (9): 1346-53. Adjei Araba A, Salavaggione Oreste E, Mandrekar Sumithra J, Dy Grace K, Ziegler Katie L Allen, Endo Chiaki, Molina Julian R, Schild Steven E, Adjei Alex |
| Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011 Dec . Smit EF, Socinski MA, Mullaney BP, Myrand SP, Scagliotti GV, Lorigan P, Reck M, Ciuleanu T, von Pawel J, Karaseva NA, Szczesna A, Ohannesian D, Powell E, Hozak RR, Hong S, Guba SC, Thatcher N |
| Genetic polymorphisms in metabolic and cellular transport pathway of methotrexate impact clinical outcome of methotrexate monotherapy in Japanese patients with rheumatoid arthritis. Drug metabolism and pharmacokinetics 2012 27 (2): 192-9. Kato Tomomi, Hamada Akinobu, Mori Shunsuke, Saito Hideyu |
| Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis. British journal of clinical pharmacology 2011 Feb 71 (2): 237-43. Yanagimachi Masakatsu, Naruto Takuya, Hara Takuma, Kikuchi Masako, Hara Ryoki, Miyamae Takako, Imagawa Tomoyuki, Mori Masaaki, Kaneko Tetsuji, Morita Satoshi, Goto Hiroaki, Yokota Shump |
| Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin. Lung cancer (Amsterdam, Netherlands) 2012 Oct 78 (1): 92-9. Tiseo Marcello, Giovannetti Elisa, Tibaldi Carmelo, Camerini Andrea, Di Costanzo Francesco, Barbieri Fausto, Burgers Jacobus A, Vincent Andrew, Peters Godefridus J, Smit Egbert F, Ardizzoni Andr |
| Association of the TYMS 3G/3G genotype with poor response and GGH 354GG genotype with the bone marrow toxicity of the methotrexate in RA patients. European journal of clinical pharmacology 2013 Mar 69 (3): 377-83. Jekic Biljana, Lukovic Ljiljana, Bunjevacki Vera, Milic Vera, Novakovic Ivana, Damnjanovic Tatjana, Milasin Jelena, Popovic Branka, Maksimovic Nela, Damjanov Nemanja, Radunovic Goran, Kovacevic Ljiljana, Krajinovic Ma |
| ABCB1 C3435T genetic polymorphism on population pharmacokinetics of methotrexate after hematopoietic stem cell transplantation in Korean patients: a prospective analysis. Clinical therapeutics 2012 Jul . Kim IW, Yun HY, Choi B, Han H, Park SY, Lee ES, Oh JM |
| Folate network genetic variation predicts cardiovascular disease risk in non-Hispanic white males. The Journal of nutrition 2012 Jul 142 (7): 1272-9. Wernimont Susan M, Clark Andrew G, Stover Patrick J, Wells Martin T, Litonjua Augusto A, Weiss Scott T, Gaziano J Michael, Vokonas Pantel S, Tucker Katherine L, Cassano Patricia |
| Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis. PloS one 2013 8 (8): e69843. Lautner-Csorba Orsolya, Gézsi András, Erdélyi Dániel J, Hullám Gábor, Antal Péter, Semsei Ágnes F, Kutszegi Nóra, Kovács Gábor, Falus András, Szalai Csa |
| Pharmacogenetics of pemetrexed combination therapy in lung cancer: pathway analysis reveals novel toxicity associations. The pharmacogenomics journal 2014 Oct 14 (5): 411-7. Corrigan A, Walker J L, Wickramasinghe S, Hernandez M A, Newhouse S J, Folarin A A, Lewis C M, Sanderson J D, Spicer J, Marinaki A |
| Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis. Clinical and experimental rheumatology 0 32 (3): 324-32. Davis L A, Polk B, Mann A, Wolff R K, Kerr G S, Reimold A M, Cannon G W, Mikuls T R, Caplan |
| Preliminary study for predicting better methotrexate efficacy in Japanese patients with rheumatoid arthritis. Journal of pharmaceutical health care and sciences 2016 2 13. Hashiguchi Masayuki, Tsuru Tomomi, Miyawaki Kumika, Suzaki Midori, Hakamata Jun, Shimizu Mikiko, Irie Shin, Mochizuki Mayu |
| SLCO1B1 rs4149056 genetic polymorphism predicting methotrexate toxicity in Chinese patients with non-Hodgkin lymphoma. Pharmacogenomics 2017 Nov . Yang Lin, Wu Hui, Gelder Teun van, Matic Maja, Ruan Jun-Shan, Han Yong, Xie Rui-Xia |
| Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates. Molecular cancer therapeutics 2019 Oct . Malhotra Usha, Mukherjee Sarbajit, Fountzilas Christos, Boland Patrick, Miller Austin, Patnaik Santosh, Attwood Kristopher, Yendamuri Sai, Adjei Araba, Kannisto Eric, Opyrchal Mateusz, Bushunow Peter, Loud Peter, Iyer Renuka, Khushalani Nikh |
| Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer. Thorax 2021 Apr . Visser Sabine, Koolen Stijn, van Donk Nadine, van Walree Nico, van der Leest Cor, Cornelissen Robin, van Schaik Ron, Mathijssen Ron, Aerts Joachim, Stricker Bruno |
| Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis. Pharmaceutics 2023 6 15 (6): . Francisco C Ceballos, Eugenio Chamizo-Carmona, Carmen Mata-Martín, Carmen Carrasco-Cubero, Juan J Aznar-Sánchez, Raúl Veroz-González, Sara Rojas-Herrera, Pedro Dorado, Adrián LLere |
- Page last reviewed:Feb 1, 2024
- Content source: